Feedback #FDBK – Interim Report for the six months ended 30 November 2017

Cambridge, UK – 26 February 2018: Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces its unaudited results for the six months ended 30 November 2017.  Operational highlights (including post-period end)1 ·      Exclusive TexRAD® distributor agreements signed in China and Korea ·      CE marked release of TexRAD® Lung ·      Three pilot TexRAD® Lung installations secured with existing research customers ·      Significant TexRAD® research […]

Feedback #FDBK – Result of AGM

Feedback #FDBK – Result of Annual General Meeting The Company announces that at the annual general meeting of the Company held earlier today, all resolutions were duly passed. For further information, please contact:  Feedback plc Dr Alastair Riddell, Chairman Lara Mott, Investor Relations Tel: 01954 718072 hello@fbk.com Allenby Capital Limited (Nominated Adviser and Joint Broker) […]

Feedback #FDBK – Presentation at RSNA 2017

Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces that Dr Balaji Ganeshan will be presenting at the 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (“RSNA 2017”) taking place from 26 November to 1 December 2017 in Chicagbalajio (IL), USA. The details for the oral presentation on the […]

Feedback plc #FDBK – First CE marked release of TexRAD® technology

Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces the first CE marked release of TexRAD®; the Company’s patented quantitative image texture analysis technology for diagnostic radiological scans. TexRAD® has the potential to assist clinicians in diagnosis, prognosis and treatment of patients with cancer and is currently installed in over 40 of the world’s […]

Proactive Investment Overview – Feedback PLC’s eye on the prize: a CE mark for TexRAD

ProActive Investors by Senior Equities Reporter John Harrington INVESTMENTOVERVIEW: FDBK THE BIGPICTURE Feedback owns a smart piece of software that analyses medical images to reveal features that are not always evident to the human eye. The CE mark will enable Feedback to market not just to scientists, but radiologists everywhere, which should lead to a marked […]

Feedback (FDBK) – Progress with CE mark and trading update

Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to update shareholders on obtaining the CE Mark for TexRAD. The Group had previously announced its expectation of obtaining the CE mark for TexRAD Lung by a target date of end May 2017.  In the course of development and review in compliance with ISO […]